Soleus Capital Management’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-21,600	Closed	-$332K	–	112
2023 Q2	$332K	Sell	21,600 -213,000	-91%	-$3.27M	0.04%	99
2023 Q1	$5.28M	Buy	+234,600	New	+$5.28M	0.55%	48
2021 Q4	–	Sell	-210,815	Closed	-$5.11M	–	86
2021 Q3	$5.11M	Buy	+210,815	New	+$5.11M	0.8%	37